MedPath

Effect of exercise in patients with cardiac disease

Not Applicable
Conditions
Cardiac patients rehabilitation.
Registration Number
IRCT20210927052610N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
62
Inclusion Criteria

Cardiac out put more than 40%
No ventricular arrhytmias and atrial fibrillation
Having a normal answer to exercise test
Age of 30_75 years
Clinically stable

Exclusion Criteria

Arrhythmia and uncontrolled blood pressure
Uncontrolled Diabetes
Systemic and pulmonary diseases limiting exercise
Physical disabilities and any restrictive exercise conditions
Severe valvular cardiac disease and known or suspected aortic dissection
Patient dissatisfaction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: The quality of life questionnaire sf36 is completed before the start of the rehabilitation program and after the completion of rehabilitation sessions. Method of measurement: Quality of Life Questionnaire short form 36.;Lipid profile and fasting blood glucose. Timepoint: Lipid profile and fasting blood glucose is measured before the start of the rehabilitation program and after the completion of rehabilitation sessions. Method of measurement: Level of fasting blood glucose and lipid profile is measured in labratory via Through blood sampling.;Treatment adherence. Timepoint: The treatment adherence form is completed at the beginning and end of the rehabilitation program. Method of measurement: Treatment adherence medanlo questionnaire.
Secondary Outcome Measures
NameTimeMethod
Quality of life score. Timepoint: Sf36 form is completed before exercise and after 36 exercise sessions. Method of measurement: Short Form 36 quality of life questionnaire.;Treatment adherence score. Timepoint: Modanloo questionarer form is completed before exercise and after 36 exercise sessions. Method of measurement: Treatment Adherence madanloo questionnaire.;Lipid profile level. Timepoint: Lipid profile is measured before the start of exercise and after 36 sessions of rehabilitation. Method of measurement: Blood lipids are measured in the laboratory through a blood sample.;Fasting blood glucose. Timepoint: Fasting blood sugar levels are measured before exercise and after 36 sessions of rehabilitation. Method of measurement: Fasting blood glucose is measured in the laboratory through a blood sample.;Blood pressure level. Timepoint: At the beginning of the rehabilitation program and at the end of the rehabilitation sessions. Method of measurement: Use a sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath